Schelker, Roland Christian and Huber, Elisabeth and Herr, Wolfgang and Vogelhuber, Martin (2016) Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase. LEUKEMIA & LYMPHOMA, 57 (1). pp. 219-222. ISSN 1042-8194, 1029-2403
Full text not available from this repository. (Request a copy)| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | CHRONIC MYELOID-LEUKEMIA; BONE-MARROW FIBROSIS; BCR-ABL; IMATINIB; THERAPY |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Medicine > Lehrstuhl für Pathologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 27 Jul 2023 05:51 |
| Last Modified: | 27 Jul 2023 05:51 |
| URI: | https://pred.uni-regensburg.de/id/eprint/2564 |
Actions (login required)
 |
View Item |
